Cargando…
Safety and Effectiveness of Bolus Insulin Aspart in People with Type 2 Diabetes: A(1)chieve Sub-Analysis
INTRODUCTION: This sub-analysis evaluated clinical safety and effectiveness of bolus insulin aspart [with/without oral glucose-lowering drugs (OGLDs)] as the only insulin therapy. METHODS: A(1)chieve was an international, multicenter, prospective, open-label, non-interventional, observational, 24-we...
Autores principales: | Randeree, Hoosen, Liebl, Andreas, Hajjaji, Issam, Khamseh, Mohammad, Zajdenverg, Lenita, Chen, Jian-Wen, Haddad, Jihad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687096/ https://www.ncbi.nlm.nih.gov/pubmed/23757032 http://dx.doi.org/10.1007/s13300-013-0026-y |
Ejemplares similares
-
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A(1)chieve Sub-Analysis
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2013) -
Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interventional A(1)chieve Study
por: Hajjaji, Issam, et al.
Publicado: (2014) -
Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A(1)chieve Study Results
por: Latif, Zafar A., et al.
Publicado: (2013) -
Clinical experience with biphasic insulin aspart in people with type 2 diabetes: Results from the Libya cohort of the A(1)chieve study
por: Hajjaji, Issam M., et al.
Publicado: (2013) -
Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A(1) chieve study
por: Bhattacharyya, Arpandev, et al.
Publicado: (2014)